The following Evaluation reports have been archived and are no longer available as
downloads from this website. If you would like to have access to any of the documents listed please contact Prescribing Support
Evaluation Reports Archive
Date
Bevacizumab in metastatic breast cancer (N)
Sep 07
Entecavir in chronic hepatitis B (N)
Apr 07
Natalizumab in multiple sclerosis (N)
Mar 07
Aromatase inhibitors in early stage breast cancer (N)
Mar 07
Alemtuzumab in chronic lymphocytic leukaemia
Mar 07
Palonosetron for the prevention of nausea and vomiting associated with cancer chemotherapy
Mar 07
Omalizumab in severe persistent allergic asthma (N)
Jun 06
Rituximab in combination with cvp chemotherapy for the management of follicular non-hodgkin’s lymphoma
Mar 06
Ibritumomab in b-cell follicular non-hodgkin’s lymphoma
Mar 06
Erlotinib in non-small cell lung cancer
Mar 06
Docetaxel or paclitaxel in early stage breast cancer (N)
Mar 06
Bortezomib second-line in multiple myeloma (N)
Mar 06
Pemetrexed in malignant pleural mesothelioma (N)
Mar 06
Pegvisomant in acromegaly
Jan 06
Ibandronic acid in hypercalcaemia of malignancy, bone pain and the prevention of skeletal events associated with skeletal metastases
Aug 05
Teriparatide in osteoporosis (N)
Jul 04
Adefovir dipivoxil in chronic hepatitis B infection (N)
Jun 04
An update on newer agents for the treatment of pulmonary hypertension
